Test a new pulsed-field catheter procedure for atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new pulsed-field device used during an atrial fibrillation (AF) catheter ablation, aiming to improve safety and effectiveness. It’s for people who have AF and are planning an AF ablation procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with atrial fibrillation within the past 12 months
- You are planning a catheter ablation for AF
- You are 18 to 75 years old
- You have not had any prior ablation in the left or right atrium
- You do not have major heart or health issues that prevent the procedure (for example, serious heart failure, recent heart attack, or significant heart valve problems)
- You are not currently in the ICU and do not have an active whole-body infection (sepsis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This study gathers real-world data on people having a procedure called pulsed field ablation for atrial fibrillation (an irregular heartbeat). It helps doctors learn how well the Globe system works in everyday practice.
This study tests a new type of energy called pulsed field ablation to treat atrial fibrillation, an irregular heartbeat. It aims to see if it is safe and effective for people whose symptoms have not improved with medication.
This trial tests a new type of heart procedure that uses gentle electrical pulses to fix abnormal signals in the upper chambers of the heart for people with a specific type of atrial fibrillation that comes and goes on its own. It may be an option if your AFib episodes stop within 7 days and medications haven't helped enough.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.